b and y ions: how MS/MS fragmentation confirms a synthetic peptide sequence

A deconvoluted intact mass is the most common identity statement on a certificate of analysis, and it is a useful one: if the measured monoisotopic mass agrees with the calculated value within a few parts per million, the elemental composition is almost certainly correct. What an intact mass cannot show is the order of the residues. Two peptides containing the same amino acids in a different sequence have identical masses, and so do a correct peptide and one in which two adjacent residues were transposed during synthesis. Tandem mass spectrometry (MS/MS) addresses this gap by breaking the peptide into pieces whose masses carry positional information.

This post describes how peptide ions fragment, how the resulting b and y ion series are read, what additional fragment types are used for modified or difficult sequences, and where the limits of the technique lie. The discussion concerns analytical interpretation only.

How a peptide ion is fragmented

In a typical workflow the peptide is ionized by electrospray, producing a distribution of multiply protonated species. A single charge state, the precursor, is isolated by the first mass analyzer and accelerated into a collision cell containing an inert gas such as nitrogen or argon. Repeated collisions convert kinetic energy into internal vibrational energy, and the peptide dissociates along its backbone. The fragments are then mass-analyzed, giving a spectrum in which each peak corresponds to a piece of the original molecule. This process is termed collision-induced dissociation (CID), and a closely related beam-type variant is commonly implemented as higher-energy collisional dissociation (HCD).

The mobile proton model is the usual framework for explaining where cleavage occurs. Protons initially reside on the most basic sites, such as the N-terminal amine, arginine, lysine, and histidine side chains. Collisional heating allows a proton to migrate to a backbone amide nitrogen, weakening the adjacent amide bond and promoting cleavage. Because migration can occur at any amide position, cleavage is distributed along the whole backbone, which is what produces a ladder of fragments rather than a single break. When a peptide contains a strongly basic residue and few mobile protons, as can happen with arginine-rich sequences at low charge states, fragmentation is less uniform and spectra can be sparse.

The b and y nomenclature

The backbone of a peptide is a repeating sequence of three bonds per residue: the amide nitrogen to alpha carbon (N–Cα), the alpha carbon to carbonyl carbon (Cα–C), and the carbonyl carbon to the next amide nitrogen (C–N). Cleavage at each of these three positions gives a different fragment type, labeled a, b, c when the charge is retained on the N-terminal piece and x, y, z when it is retained on the C-terminal piece. Under low-energy CID the dominant cleavage is at the amide bond itself, the C–N bond, and the products are therefore b ions (N-terminal) and y ions (C-terminal).

The subscript on each ion states how many residues it contains. A b₃ ion contains the first three residues counted from the N-terminus, while a y₃ ion contains the last three counted from the C-terminus. A peptide of n residues thus yields complementary pairs in which bᵢ and yₙ₋ᵢ together account for the whole molecule. Their masses follow simple arithmetic. A b ion equals the sum of its residue masses plus one proton, and a y ion equals the sum of its residue masses plus one water and one proton. Consecutive members of a series differ by the mass of a single residue, so the spacing between adjacent peaks identifies the amino acid at that position.

Reading a ladder and what it establishes

To confirm a sequence, the analyst compares the observed fragment masses with those predicted for the expected peptide, and checks that the series is continuous. A complete y-series from y₁ to yₙ₋₁ establishes the sequence from the C-terminus; a complete b-series does the same from the N-terminus. Where both series are present, each residue is supported by two independent mass differences, and coverage is typically reported as the fraction of backbone bonds for which a fragment was observed.

Several features of real spectra are worth noting. Fragment intensity is strongly sequence-dependent. Cleavage on the N-terminal side of proline is typically enhanced, producing an abundant y ion, whereas cleavage C-terminal to proline is suppressed. Acidic residues promote cleavage at their own C-terminal side when the charge is sequestered elsewhere. Leucine and isoleucine are isobaric and cannot be distinguished by low-energy CID alone, a limitation that matters when a sequence contains both. Small b ions, particularly b₁, are often absent because they are unstable, and low-mass regions may be obscured by immonium ions and by the lower-mass cutoff of some ion trap instruments.

A practical consequence is that sequence coverage should be reported rather than assumed. A spectrum that matches the expected sequence at most positions but leaves one or two bonds unobserved supports the identity without proving every residue; the unobserved region is exactly where a transposition or single-residue difference could hide. Increasing coverage may require acquisition at a different charge state, a different collision energy, or an alternative fragmentation technique.

Complementary fragmentation and modified residues

Electron-based methods, electron-transfer dissociation (ETD) and electron-capture dissociation (ECD), cleave the N–Cα bond instead and generate c and z-type ions. Because the process is less dependent on proton mobility and tends to leave labile side-chain modifications intact, these techniques are valuable for peptides carrying phosphate, glycan, or other fragile groups, and for longer or highly charged species. They also cleave on the N-terminal side of proline, which CID handles poorly. Instruments that offer both modes allow the two ion families to be combined, giving overlapping coverage.

Synthetic peptides introduce their own interpretive issues. N-terminal acetylation shifts every b ion by 42.011 Da while leaving y ions unchanged, and C-terminal amidation shifts every y ion by about one Da relative to the free acid, so a mass offset that is consistent across one series and absent from the other localizes a terminal modification. Disulfide-linked peptides give fragments that remain connected through the bridge, so cleavage within a loop may not release a fragment until the bond is reduced or cleaved by a different method. Cyclic peptides require two backbone cleavages to produce a fragment, which complicates the spectrum considerably. Neutral losses, most commonly water from serine, threonine, aspartate, and glutamate, and ammonia from lysine, arginine, asparagine, and glutamine, add satellite peaks 18 and 17 Da below the main ions and are used as supporting evidence rather than noise.

Limits and complementary evidence

MS/MS sequence confirmation is a statement about the major species selected for fragmentation. Co-eluting impurities with different masses are excluded at the isolation step, so the technique is not a purity measurement; an impurity that shares the precursor m/z, such as a deamidated form close to the parent in an unresolved isotope envelope, may fragment into a mixed spectrum that is harder to interpret. Likewise, a deletion or truncation impurity present at a fraction of a percent is usually below the level at which it would be noticed in a fragmentation spectrum of the main component. Chromatographic purity, orthogonal separation, and quantitative measures of peptide content address these questions, and are reported separately for that reason.

Interpretation also depends on the tooling. Fragment lists are generated by software that must be told about every expected modification, protecting group remnant, and non-standard residue, and mismatches between the declared and actual structure can produce a plausible-looking but incorrect assignment. Reporting the instrument, fragmentation mode, collision energy, charge state of the precursor, and coverage achieved allows another laboratory to judge how much weight the spectrum can bear.

Taken together, b and y ion series convert a mass measurement into a sequence-level observation. The strength of the evidence scales with coverage, with the number of independent ions supporting each residue, and with the degree to which isobaric ambiguities such as Leu/Ile are acknowledged. Read alongside intact-mass agreement, retention behavior, and purity data, the fragmentation spectrum is one component of the broader body of analytical characterization used to describe a synthetic peptide.